Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial. (2021)

First Author: CRASH-3 Intracranial Bleeding Mechanistic Study Collaborators
Attributed to:  The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00068-020-01316-1

PubMed Identifier: 32076783

Publication URI: http://europepmc.org/abstract/MED/32076783

Type: Journal Article/Review

Volume: 47

Parent Publication: European journal of trauma and emergency surgery : official publication of the European Trauma Society

Issue: 1

ISSN: 1863-9933